NCT05661201 2026-03-06
NEROFE and Doxorubicin in KRAS-mutated ST2-positive Solid Tumors
Georgetown University
Phase 1 Recruiting
Clinical Trials
3 trialsNCT03059615 2020-07-31
A Phase 2a, Open-Label, Two Stage Study of Nerofe or Nerofe With Doxorubicin in Subjects With AML or MDS
Immune System Key Ltd
Phase 2 Withdrawn
NCT01690741 2018-06-25
Phase 1 Trial of Intravenously Administered Nerofeâ„¢ in Subjects With Advanced Malignancies
Immune System Key Ltd
Phase 1 Completed